by Madaline Spencer | Aug 30, 2024
David Katz, PhD, Chief Scientific Officer and Founder of Sparrow Pharmaceuticals, discusses how clofutriben addresses the challenges of hypercortisolism in Cushing’s syndrome. Cushing’s syndrome is a rare endocrine disorder caused by prolonged...
by Madaline Spencer | Aug 29, 2024
Carla Nester, MD, professor at the University of Iowa and lead principal investigator for the VALIANT study, discusses the clinical trial testing pegcetacoplan in patients with C3G and primary IC-MPGN. Complement 3 glomerulopathy (C3G) and immune-complex...
by Madaline Spencer | Aug 28, 2024
Bruce Cree, MD, PhD, Professor of Clinical Neurology at the University of California San Francisco, discusses a post hoc analysis of patient pain and quality of life data in treatment with Uplizna (inebilizumab-cdon) for neuromyelitis optica. ...
by Madaline Spencer | Aug 27, 2024
Anita Longoria, a patient advocate, discusses her journey to a myasthenia gravis (MG) diagnosis. Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal muscles. Common symptoms include weakness of...
by Madaline Spencer | Aug 26, 2024
Prem Subramanian, MD, PhD, Professor of Ophthalmology at the University of Colorado School of Medicine, discusses long-term data testing teprotumumab in patients with thyroid eye disease (TED). TED is a rare autoimmune disease that can dramatically...
